Literature DB >> 12032037

Continuous psoas compartment block for postoperative analgesia after total hip arthroplasty: new landmarks, technical guidelines, and clinical evaluation.

Xavier Capdevila1, Philippe Macaire, Christophe Dadure, Olivier Choquet, Philippe Biboulet, Yves Ryckwaert, Françoise D'Athis.   

Abstract

UNLABELLED: A computed tomographic scan was obtained in 35 patients to measure the depth and the relationship of the branches of the lumbar plexus to the posterior superior iliac spine projection and the vertebral column. In addition, we prospectively studied 80 patients scheduled for total hip arthroplasty who received a continuous psoas compartment block (CPCB) in the postoperative period. CPCB was performed after surgical procedures by using modified Winnie's landmarks and nerve stimulation. From 5 to 8 cm of catheter was inserted. Radiographs were obtained after injection of 10 mL of contrast medium. An initial loading dose (0.4 mL/kg) of 0.2% ropivacaine was injected, followed by continuous infusion of 0.2% ropivacaine for 48 h. The depth of the lumbar plexus and the distance between the lumbar plexus and the L4 transverse process were measured. Visual analog scale values of pain at 1, 12, 24, and 48 h were obtained at rest and during mobilization. Amounts of rescue analgesia were also recorded. Sensory blockade of the principal branches of the lumbosacral plexus was noted at 1 and 24 h, as were adverse events related to the technique. There was a significant difference between men and women in depth of the lumbar plexus (median values, 85 vs 70 mm for men and women, respectively). There was a positive correlation between the body mass index and skin-lumbar plexus distances. In contrast, there was no difference regarding the distance between the transverse process of L4 and the lumbar plexus. The catheter tip lay within the psoas major muscle in 74% of the patients and between the psoas and quadratus lumborum muscles in 22%. In three patients, the catheter was improperly positioned. At 1 h, sensory blockade of the femoral, obturator, and lateral femoral cutaneous nerves was successful in, respectively, 95%, 90%, and 85% of patients. At 24 h, these rates were 88%, 88%, and 83%, respectively. During the 48-h study period, median visual analog scale values of pain were approximately 10 mm at rest and from 18 to 25 mm during physiotherapy. Five patients received 5 mg of morphine at 1 h. Five cases of unilateral epidural anesthesia were noted after the bolus injection. We conclude that CPCB with 0.2% ropivacaine allows optimal analgesia after hip arthroplasty, with few side effects and a small failure rate. Before lumbar plexus branch stimulation and catheter insertion, anesthesiologists should be aware of the L4 transverse process location and lumbar plexus depth. IMPLICATIONS: Lumbar plexus depth is correlated with the patient's body mass index and differs between men and women, but this is not true of the lumbar plexus-transverse process distance. Considering new landmarks, a continuous psoas compartment block promotes optimal analgesia after hip arthroplasty, with few side effects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032037     DOI: 10.1097/00000539-200206000-00045

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  34 in total

1.  Incidence of lateral femoral cutaneous nerve neuropraxia after anterior approach hip arthroplasty.

Authors:  Krista Goulding; Paul E Beaulé; Paul R Kim; Anna Fazekas
Journal:  Clin Orthop Relat Res       Date:  2010-09       Impact factor: 4.176

Review 2.  Peripheral nerve blocks for perioperative management of patients having orthopedic surgery or trauma of the lower extremity.

Authors:  Takashige Iwata; Sundaram Lakshman; Alpana Singh; Marina Yufa; Rich Claudio; Admir Hadzić
Journal:  Bosn J Basic Med Sci       Date:  2005-05       Impact factor: 3.363

Review 3.  Nerve blocks or no nerve blocks for pain control after elective hip replacement (arthroplasty) surgery in adults.

Authors:  Joanne Guay; Rebecca L Johnson; Sandra Kopp
Journal:  Cochrane Database Syst Rev       Date:  2017-10-31

Review 4.  [Peripheral nerve blocks of the lower extremities. Clinical and practical aspects].

Authors:  A W Reske; A P Reske; V Meier; M Wiegel
Journal:  Anaesthesist       Date:  2009-10       Impact factor: 1.041

5.  Is L2 paravertebral block comparable to lumbar plexus block for postoperative analgesia after total hip arthroplasty?

Authors:  Richa Wardhan; Anne-Sophie M Auroux; Bruce Ben-David; Jacques E Chelly
Journal:  Clin Orthop Relat Res       Date:  2014-05       Impact factor: 4.176

6.  Ultrasound-guided peripheral nerve blocks for anterior cruciate ligament reconstruction: effect of obturator nerve block during and after surgery.

Authors:  Shinichi Sakura; Kaoru Hara; Junichi Ota; Saki Tadenuma
Journal:  J Anesth       Date:  2010-03-12       Impact factor: 2.078

7.  Continuous femoral versus posterior lumbar plexus nerve blocks for analgesia after hip arthroplasty: a randomized, controlled study.

Authors:  Brian M Ilfeld; Edward R Mariano; Sarah J Madison; Vanessa J Loland; NavParkash S Sandhu; Preetham J Suresh; Michael L Bishop; T Edward Kim; Michael C Donohue; Anna A Kulidjian; Scott T Ball
Journal:  Anesth Analg       Date:  2011-04-05       Impact factor: 5.108

Review 8.  Perioperative pain control after total knee arthroplasty: An evidence based review of the role of peripheral nerve blocks.

Authors:  Thomas Danninger; Mathias Opperer; Stavros G Memtsoudis
Journal:  World J Orthop       Date:  2014-07-18

9.  Lower limb orthopedic surgery in geriatric patients under paravertebral blocks: A prospective feasibility study.

Authors:  Rajesh Kumar Singh; J P Chaturvedi; H S Agrawal; Nitesh Agrawal
Journal:  Med J Armed Forces India       Date:  2016-05-26

10.  One operator's experience of ultrasound guided lumbar plexus block for paediatric hip surgery.

Authors:  Yavuz Gürkan; Can Aksu; Alparslan Kuş; Kamil Toker; Mine Solak
Journal:  J Clin Monit Comput       Date:  2016-03-31       Impact factor: 2.502

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.